Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Operating Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹2,515 Cr₹190,193 Cr₹1,991 Cr₹165 Cr₹14,447 Cr

What is the latest Operating Profit of MANKIND PHARMA ?

The latest Operating Profit ratio of MANKIND PHARMA is ₹2,515 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹2,515 Cr
Mar2024₹190,193 Cr
Mar2023₹1,991 Cr
Mar2022₹165 Cr
Mar2021₹14,447 Cr

How is Operating Profit of MANKIND PHARMA Trending?

Years Operating Profit % Change
Mar2025 ₹2,515 Cr
-98.68
Mar2024 ₹190,193 Cr
9,454.83
Mar2023 ₹1,991 Cr
1,107.04
Mar2022 ₹165 Cr
-98.86
Mar2021 ₹14,447 Cr -

Compare Operating Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹82,454.7 Cr -1.1% -11.1% -16.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.1%

-11.1%

-16.9%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses